Literature DB >> 2478861

Increased levels of acute-phase serum proteins in diabetes.

D E McMillan1.   

Abstract

Serum viscosity's increase in diabetes has been linked to the presence of microvascular sequelae and to changes in serum protein composition. The major change is a decline in albumin and an increase in the levels of acute-phase proteins. In this study, albumin and five acute phase proteins--alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin, ceruloplasmin, and C-reactive protein--were measured. Levels in adult diabetes (principally type II) were compared with those in both subjects with glucose intolerance and control subjects (healthy subjects and nondiabetic ambulatory patients). Haptoglobin, alpha-1 acid glycoprotein, and C-reactive protein increased markedly in both diabetes and glucose intolerance; ceruloplasmin and alpha-1 antitrypsin increased more marginally. Serum albumin level decreased more strikingly as hyperglycemia advanced. Acute-phase proteins also increased in advanced glucose intolerance as in established diabetes. The acute-phase protein elevation did not differ with degree of control or duration of diabetes. When diabetics were divided into those with and without clinically detectable evidence of microvascular sequelae, elevation of haptoglobin, C-reactive protein and alpha-1 acid glycoprotein, and depression of albumin were found to progress with number of sequelae. The levels of these proteins, particularly haptoglobin, were also highly correlated with serum viscosity expressed as viscosity number. Mild serum albumin depression and a more striking acute-phase protein elevation are greater in diabetes with microangiopathy, develop in glucose intolerance, and contribute substantially to elevated plasma viscosity in diabetes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478861     DOI: 10.1016/0026-0495(89)90038-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  38 in total

1.  Common variations in the genes encoding C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, and the risk of clinical diabetes in the Women's Health Initiative Observational Study.

Authors:  Kei-hang K Chan; Kathleen Brennan; Nai-chieh Y You; Xuyang Lu; Yiqing Song; Yi-Hsiang Hsu; Gautum Chaudhuri; Lauren Nathan; Lesley Tinker; Simin Liu
Journal:  Clin Chem       Date:  2010-12-13       Impact factor: 8.327

2.  Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.

Authors:  Rosalinda Madonna; Yong-Jian Geng; Roberto Bolli; Gregg Rokosh; Peter Ferdinandy; Cam Patterson; Raffaele De Caterina
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

Review 3.  Intake of sugar-sweetened beverages and weight gain: a systematic review.

Authors:  Vasanti S Malik; Matthias B Schulze; Frank B Hu
Journal:  Am J Clin Nutr       Date:  2006-08       Impact factor: 7.045

4.  Haptoglobin and the inflammatory and oxidative status in experimental diabetic rats: antioxidant role of haptoglobin.

Authors:  Arambašić Jelena; Mihailović Mirjana; Bogojević Desanka; Ivanović-Matić Svetlana; Uskoković Aleksandra; Poznanović Goran; Grigorov Ilijana
Journal:  J Physiol Biochem       Date:  2012-06-19       Impact factor: 4.158

5.  Characterizing Hand Infections in an Underserved Population: The Role of Diabetic Status in Antibiotic Choice and Infection Location.

Authors:  Andrew J Hayden; Neil V Shah; Sarah G Stroud; Gregory S Penny; Steven A Burekhovich; Aadit T Shah; Erika Kuehn; Andrew Yang; Bassel G Diebo; Steven M Koehler
Journal:  J Hand Microsurg       Date:  2019-06-26

6.  Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome.

Authors:  Daad Hassan Akbar
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

7.  HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study.

Authors:  S S Rich; L R French; J M Sprafka; J P Clements; F C Goetz
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

8.  Ankylosing spondylitis and other inflammatory spondyloarthritis increase the risk of developing type 2 diabetes in an Asian population.

Authors:  Hsin-Hung Chen; Su-Yin Yeh; Hue-Yong Chen; Cheng-Li Lin; Fung-Chang Sung; Chia-Hung Kao
Journal:  Rheumatol Int       Date:  2013-12-22       Impact factor: 2.631

Review 9.  Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.

Authors:  Marc Y Donath; Joachim Størling; Kathrin Maedler; Thomas Mandrup-Poulsen
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

10.  Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus.

Authors:  T S Trovik; R Jaeger; R Jorde; O Ingebretsen; G Sager
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.